New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice

Clémence M. Canivet, Jérôme Boursier, Rohit Loomba

Open source

DOI
10.1055/s-0044-1785196
Published
2024-02
Container
Seminars in Liver Disease
Publisher
Georg Thieme Verlag KG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/s-0044-1785196,
  title = {New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice},
  author = {Clémence M. Canivet and Jérôme Boursier and Rohit Loomba},
  year = {2024},
  journal = {Seminars in Liver Disease},
  doi = {10.1055/s-0044-1785196},
  url = {https://doi.org/10.1055/s-0044-1785196}
}

RIS

TY  - JOUR
TI  - New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice
AU  - Clémence M. Canivet
AU  - Jérôme Boursier
AU  - Rohit Loomba
PY  - 2024
JO  - Seminars in Liver Disease
DO  - 10.1055/s-0044-1785196
UR  - https://doi.org/10.1055/s-0044-1785196
ER  - 

APA

Canivet, C. M., Boursier, J., & Loomba, R. (2024). New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice. Seminars in Liver Disease. https://doi.org/10.1055/s-0044-1785196

Source records